Nur Fadhilah Abu Bakar1*, Murnihayati Hassan1, Salina Mohamed Sukur1, Rohaidah Hashim1
1. Bacteriology Unit, Infectious Disease Research Centre (IDRC), Institute for Medical Research (IMR), National Institutes of Health, Ministry of Health Malaysia
*Corresponding author: Nur Fadhilah Abu Bakar.
ABSTRACT
INTRODUCTION: Ustilago species, typically known as plant pathogens, have increasingly been recognized as opportunistic fungi capable of causing infections in humans, particularly among immunocompromised individuals. Although rare, Ustilago infections in humans deserve attention because they are hard to diagnose and have limited treatment options. In Malaysia, data on the occurrence and characteristics of Ustilago infections remain scarce.
OBJECTIVE(S): This study was conducted to analyze the epidemiological trends, clinical sources, and antifungal profiles of Ustilago species isolated in Malaysia from 2020 to 2024.
MATERIALS & METHODS: All recorded cases of Ustilago infection were retrieved from IMR laboratory database covering the period from 2020 to 2024. Subsequently, the data were analyzed to determine the distribution and antifungal susceptibility patterns.
RESULTS: A total of 8908 fungal isolates were gained from various hospitals in Malaysia. A total of 22 Ustilago isolates were identified over the study period. Although uncommon, the number of cases has gradually increased. Moreover, most of the Ustilago infections were found from blood (n=15) and peritoneal fluid (n=5). Antifungal susceptibility testing was conducted for only three Ustilago isolates. However, due to the absence of established clinical breakpoints or interpretive criteria for Ustilago species by the Clinical and Laboratory Standards Institute (CLSI), no susceptibility interpretation was performed.
CONCLUSION: Although Ustilago infections remain rare, the increasing number of cases observed over the five-year period highlights the need for greater clinical awareness and improved diagnostic recognition. The predominance of isolates from sterile sites such as blood and peritoneal fluid underscores their potential pathogenicity, particularly in immunocompromised patients. Given the lack of CLSI breakpoints for Ustilago species, standardized antifungal susceptibility guidelines are urgently needed to support effective clinical management and further research.
KEYWORDS: Ustilago, Opportunistic Fungi, Antifungal Susceptibility, Sterile Sites, Immunocompromised


